A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma

NCT05183139 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision (no enrollment)

Conditions

Multiple Myeloma

Interventions

DRUG: Ixazomib
DRUG: Pomalidomide
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Takeda